Table 1. Demographics and baseline characteristics.
| Demographic/baseline characteristics | Total population N=1328 | BBFC N=427 | Brinzolamide N=453 | Brimonidine N=448 |
|---|---|---|---|---|
| Age, years | ||||
| Mean±SD | 64.7±10.5 | 64.8±10.8 | 64.6±10.2 | 64.6±10.6 |
| <65, n (%) | 641 (48.3%) | 202 (47.3%) | 209 (46.1%) | 230 (51.3%) |
| ≥65, n (%) | 687 (51.7%) | 225 (52.7%) | 224 (53.9%) | 218 (48.7%) |
| Race, n (%) | ||||
| White | 968 (72.9%) | 317 (74.2%) | 320 (70.6%) | 331 (73.9%) |
| Black | 326 (24.5%) | 98 (23.0%) | 117 (25.8%) | 111 (24.8%) |
| Asian | 17 (1.3%) | 6 (1.4%) | 10 (2.2%) | 1 (0.2%) |
| Multi-racial | 3 (0.2%) | 0 (0.0%) | 1 (0.2%) | 2 (0.4%) |
| American Indian/Alaska Native | 1 (0.1%) | 1 (0.2%) | 0 (0.0%) | 0 (0.0%) |
| Other | 13 (1.0%) | 5 (1.2%) | 5 (1.1%) | 3 (0.7%) |
| Sex, n (%) | ||||
| Male | 552 (41.6%) | 173 (40.5%) | 194 (42.8%) | 185 (41.3%) |
| Female | 776 (58.4%) | 254 (59.5%) | 259 (57.2%) | 263 (58.7%) |
| Diagnosis, n (%) | ||||
| Ocular hypertension | 385 (29.0%) | 132 (30.9%) | 130 (28.7%) | 123 (27.5%) |
| Open-angle glaucoma | 943 (71.0%) | 295 (69.1%) | 323 (71.3%) | 325 (72.5%) |
Abbreviation: BBFC, brinzolamide 1%/brimonidine 0.2% fixed combination.
Demographics and baseline characteristics were presented from the intent-to-treat population.